Federal contract award
75A50124C00004
ZEEVA THERAPEUTICS CORPORATION - RESEARCH AND DEVELOPMENT AOI #19 FOR THE DEVELOPMENT OF A NOVEL TUBE JUNCTION CONNECTOR FOR BLOOD CIRCUITS IN ECMO
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $742.1K |
| Current contract value | $742.1K |
| Potential contract value / ceiling | $742.1K |
| Start date | Apr 17, 2024 |
| Current end date | Oct 16, 2025 |
| Potential end date | Oct 16, 2025 |
| Latest award activity | May 2, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 2, 2025 | P00003 | $0 | ZEEVA THERAPEUTICS CORPORATION - RESEARCH AND DEVELOPMENT AOI #19 FOR THE DEVELOPMENT OF A NOVEL TUBE JUNCTION CONNECTOR FOR BLOOD CIRCUITS IN ECMO |
| Jan 22, 2025 | P00002 | $0 | ZEEVA THERAPEUTICS CORPORATION - RESEARCH AND DEVELOPMENT AOI #19 FOR THE DEVELOPMENT OF A NOVEL TUBE JUNCTION CONNECTOR FOR BLOOD CIRCUITS IN ECMO |
| Aug 5, 2024 | P00001 | $0 | ZEEVA THERAPEUTICS CORPORATION - RESEARCH AND DEVELOPMENT AOI #19 FOR THE DEVELOPMENT OF A NOVEL TUBE JUNCTION CONNECTOR FOR BLOOD CIRCUITS IN ECMO |
| Apr 16, 2024 | 0 | $742.1K | ZEEVA THERAPEUTICS CORPORATION - RESEARCH AND DEVELOPMENT AOI #19 FOR THE DEVELOPMENT OF A NOVEL TUBE JUNCTION CONNECTOR FOR BLOOD CIRCUITS IN ECMO |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.